RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 136 filers reported holding RELAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $867,862 | -40.7% | 103,194 | -11.4% | 0.03% | -40.0% |
| Q2 2023 | $1,463,328 | +6.0% | 116,507 | +26.1% | 0.06% | -24.7% |
| Q4 2022 | $1,380,650 | +319.7% | 92,413 | +763.7% | 0.07% | +247.6% |
| Q4 2021 | $329,000 | -85.1% | 10,700 | -84.7% | 0.02% | -86.9% |
| Q3 2021 | $2,210,000 | +233.3% | 70,100 | +286.8% | 0.16% | +150.0% |
| Q2 2021 | $663,000 | – | 18,125 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |